TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Sever Pharma Solutions AB
Closing information (x1000 SEK)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
609,905
|
477,861
|
440,421 |
| Financial expenses |
5,764
|
4,002
|
2,886 |
| Earnings before taxes |
16,884
|
27,962
|
23,501 |
| EBITDA |
44,658
|
48,810
|
37,093 |
| Total assets |
546,972
|
455,704
|
429,870 |
| Current assets |
279,217
|
197,147
|
168,992 |
| Current liabilities |
193,734
|
94,271
|
72,314 |
| Equity capital |
330,652
|
227,607
|
205,861 |
| - share capital |
10,000
|
10,000
|
10,000 |
| Employees (average) |
312
|
278
|
256 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
60.5%
|
49.9%
|
47.9% |
| Turnover per employee |
1,955
|
1,719
|
1,720 |
| Profit as a percentage of turnover |
2.8%
|
5.9%
|
5.3% |
| Return on assets (ROA) |
4.1%
|
7.0%
|
6.1% |
| Current ratio |
144.1%
|
209.1%
|
233.7% |
| Return on equity (ROE) |
5.1%
|
12.3%
|
11.4% |
| Change turnover |
132,044
|
37,440
|
92,424 |
| Change turnover % |
28%
|
9%
|
27% |
| Chg. No. of employees |
34
|
22
|
55 |
| Chg. No. of employees % |
12%
|
9%
|
27% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.